Simulations Plus Inc.


SLP

Price

50.33


Change

-0.82


High

52.09


Low

NA


Avg Volume

129,409


PE Ratio

NA


52 Week High

67.59


52 Week Low

35.1



Profile

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a leading provider of clinical trial data analysis and consulting services. The company has produced specific proprietary software products, such as:


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.